4.7 Review

Recent advances on 2 '-fucosyllactose: physiological properties, applications, and production approaches

Journal

CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
Volume 62, Issue 8, Pages 2083-2092

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/10408398.2020.1850413

Keywords

Biological production; 2′ -fucosyllactose; human milk oligosaccharide; metabolic engineering; physiological properties

Funding

  1. National Natural Science Foundation of China [31922073]
  2. Key-Area Research and Development Program of Guangdong Province [2020B020226007]
  3. Zhangjiagang international cooperation project [ZKH1905]

Ask authors/readers for more resources

The trisaccharide 2'-fucosyllactose (2'-FL) is the most abundant oligosaccharide in human milk and has significant biological properties. It is approved as a safe food ingredient and has various applications in infant formula, dietary supplements, and food bioprocesses. This review provides a systematic elaboration of the functional properties and applications of 2'-FL, as well as the different approaches for its production.
The trisaccharide, 2 '-fucosyllactose (Fuc alpha 1-2Gal beta 1-4Glc; 2 '-FL), is the most abundant oligosaccharide in human milk. It has numerous significant biological properties including prebiotics, antibacterial, antiviral, and immunomodulating effects, and has been approved as generally recognized as safe (GRAS) by the Food and Drug Administration (FDA) and as a novel food (NF) by the European Food Safety Authority (EFSA). 2 '-FL not only serves as a food ingredient added in infant formula, but also as a dietary supplement and medical food material in food bioprocesses. There is considerable commercial interest in 2 '-FL for its irreplaceable nutritional applications. This review aims at systematically elaborating key functional properties of 2 '-FL as well as its applications. In addition, several approaches for 2 '-FL production are described in this review, including chemical, chemo-enzymatical, and cell factory approaches, and the pivotal research results also have been summarized. With the rapid development of metabolic engineering and synthetic biology strategies, using the engineered cell factory for 2 '-FL large-scale production might be a promising approach. From an economic and safety point of view, microbial selection for cell factory engineering in 2 '-FL bioprocess also should be taken into consideration.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available